WS
ISEE

Wedbush Securities’s IVERIC bio, Inc. Common Stock ISEE Stock Holding History

Wedbush Securities’s Portfolio ISEE Stock Details ISEE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-11,000
Closed -$62K – 1013
2020
Q3 		$62K Buy
+11,000
New +$52.5K 0.01% 865
2017
Q2 		– Sell
-17,000
Closed -$62K – 882
2017
Q1 		$62K Buy
+17,000
New +$71.8K 0.01% 794

Other funds holding ISEE

ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
FM
Frazier Management Seattle, Washington $1.12M AUM 151.58% 1-Year Est. Return

Wedbush Securities's ISEE Position: Q4 2020 in Review

Wedbush Securities sold out of IVERIC bio, Inc. Common Stock (ISEE) in Q4 2020, closing a stake of 11,000 shares — an estimated $62K sold.

Wedbush Securities first reported a position in ISEE in Q1 2017 and held it in 2 quarters. The position peaked at $62K in Q3 2020. 120 funds tracked by Wall St. Rank hold ISEE as of Q4 2020.

  • Wedbush Securities reported no remaining IVERIC bio, Inc. Common Stock position as of Q4 2020 after selling out during the quarter.
  • Wedbush Securities sold 11,000 IVERIC bio, Inc. Common Stock shares in Q4 2020, an estimated $62K.
  • Wedbush Securities first reported a position in IVERIC bio, Inc. Common Stock in Q1 2017 and held it in 2 quarters.
  • Wedbush Securities's IVERIC bio, Inc. Common Stock position peaked at $62K in Q3 2020.
  • 120 funds tracked by Wall St. Rank held IVERIC bio, Inc. Common Stock as of Q4 2020.

Based on Wedbush Securities's 13F filing for Q4 2020, filed 16 Feb 2021.